MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
about
Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrenceConstruction and analyses of the microRNA-target gene differential regulatory network in thyroid carcinomaGga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek's disease tumor cell MSB1Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylationmiR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.Ionizing radiation-induced microRNA expression changes in cultured RGC-5 cells.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.A Genetic Variant in miRNA-219-1 Is Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Kazakhs.MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.Polymorphisms in miR-135a-2, miR-219-2 and miR-211 as well as their interaction with cooking oil fume exposure on the risk of lung cancer in Chinese nonsmoking females: a case-control studyFunction and clinical potential of microRNAs in hepatocellular carcinoma.Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients.miRNA in hepatocellular carcinoma.MicroRNA regulation of proteoglycan function in cancer.Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors.Development of MicroRNA Therapeutics for Hepatocellular Carcinoma.Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.MicroRNA-219-5p Inhibits Morphine-Induced Apoptosis by Targeting Key Cell Cycle Regulator WEE1.SPARC overexpression alters microRNA expression profiles involved in tumor progressionMicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1 in glioblastoma.A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinomamiR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Clinical implications of microRNAs in liver cancer stem cells.New tumor suppressor microRNAs target glypican-3 in human liver cancer.Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA.Polymorphisms of pri-miR-219-1 are associated with the susceptibility and prognosis of non-small cell lung cancer in a Northeast Chinese population.Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells.miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin.Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis.Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219.miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI.Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection.MicroRNA-219 exerts a tumor suppressive role in glioma via targeting Sal-like protein 4.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.Protective role of microRNA-219-5p inhibitor against spinal cord injury via liver receptor homolog-1/Wnt/β-catenin signaling pathway regulation.
P2860
Q30413140-00F7EC65-5AD6-41F9-844B-DEDCFF4FF07AQ30419258-ED8C2C38-FC98-4FC6-8893-250A877350F9Q33276346-F0A511CD-4C74-41D1-9FC9-1B4BD0FDB5FAQ33751684-1FE2DB66-A5BE-4E85-9C24-5D359F823767Q33835336-EEBFCCE2-E614-4ABB-AB6D-D040819A7180Q33850265-A8810E38-D615-4CD4-9A76-A87C16B0CD94Q34699904-6D307B94-4505-4322-A96A-488375F395F4Q35055042-8FC2846B-39E5-48C5-A91B-1D87DCEB1547Q35665389-477CC1C7-37B9-4F07-87B4-03655E55D90DQ35715931-6BF37EA2-8730-4248-86A1-B199C9300BE4Q35778808-E5E59A75-7844-496B-B731-69CFB8805282Q36020979-5E657312-AC82-4AB7-B465-F31C106A7817Q36143366-C5F007A2-AFB2-40A1-B93B-BA6D53C1F89FQ36336198-D01B8D6A-06A7-4262-B1D3-80BDD7F763A7Q37299042-C598AF5C-5035-464A-8360-97CAAD4C4DBEQ38231531-042B6425-2D80-43A8-8261-5D1F8BEEADF9Q38244283-8F65592F-43B8-4160-968F-06F5B6FD52F2Q38314129-E7DBABAB-5771-4582-9945-FE6F9C2F2E2FQ38719441-5E7C5BED-FFA3-4BE5-B4FD-A0F59ED7D280Q38740040-E257BE32-C126-4995-8199-00D051EC8340Q38767023-FE248DD5-759A-4012-94E2-496E28564E7EQ38823959-35B8C63C-0B20-4BE5-BEBF-C16765C6E9C4Q38863240-32C2F620-BCBC-4917-9304-A5B55D4680E5Q38979570-62BB0FC7-F7A6-4B66-B4A2-ACAD984A8029Q39291031-C891DC37-5E06-4783-B57E-C6F8B75394C3Q39378285-9F131DE4-9307-459F-ABB7-0056C30A788FQ39419867-F40AFC8B-AFA0-4ECB-A58F-A6227B24CA3BQ41093562-54599899-34B6-494D-B356-397269352921Q41138780-1926B677-BBE9-4EE9-A546-95A8068DE422Q41345982-CE23984A-23CA-4F12-92F3-CD3AA6782415Q41776302-87649418-2713-4BCE-B234-B482FAB82A0BQ42256563-CABDB840-FE81-4E0C-97A4-E965483C446DQ42319947-2766F0A3-1A1D-4526-BCBD-EFDFE8D11924Q42367903-E1C776DB-CB49-4EA4-9CCE-9025EAB9497AQ42965204-068D9A9F-AFC4-41E5-8BD4-01EDE23438CEQ44466854-78E77682-2015-4C24-9C7A-C7A8B42B2857Q47094148-B2009C27-D33F-4E2A-AEF2-785AD31CDD3EQ47096853-C9BBC19F-188E-4794-ADF5-5B0DEAD27882Q51052957-1FA41BBE-920A-4187-B019-B828B5AB771BQ55261345-0C55BC95-3BA9-405D-A8E5-B57702D0B35B
P2860
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
@en
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
@nl
type
label
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
@en
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
@nl
prefLabel
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
@en
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
@nl
P2093
P2860
P1433
P1476
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
@en
P2093
Chengwei Lv
Dayong Zheng
Rongcheng Luo
Ruzhai Qing
P2860
P304
P356
10.1016/J.FEBSLET.2012.02.017
P407
P577
2012-02-20T00:00:00Z